COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,586 Articles (22,415 medRxiv, 8,171 bioRxiv)

Most recent first Previous |  Page 1415: Articles 14141-14150  | Next

Clinical validation of colorimetric RT-LAMP, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern
Alves, P. A., Oliveira, E. G., Franco-Luiz, A. P. M., Almeida, L. T., Goncalves, A. B., Borges, I. A., Rocha, F. S., Rocha, R. P., Bezerra, M. F., Miranda, P., Capanema, F. D., Martins, H., Weber, G., Teixeira, S. M. R., Wallau, G. L., Monte-Neto, R. L.
10.1101/2021.05.26.21257488 — Posted: 2021-06-02
The Female Predominant Persistent Immune Dysregulation of the Post COVID Syndrome: A Cohort Study
Ganesh, R., Grach, S. L., Bierle, D. M., Salonen, B. R., Collins, N. M., Joshi, A. Y., Boeder, N. D., Anstine, C. V., Mueller, M. R., Wight, E. C., Croghan, I. T., Badley, A. D., Carter, R. E., Hurt, R. T.
10.1101/2021.05.25.21257820 — Posted: 2021-06-02
Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNF-α antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure
Hachem, H., Godara, A., Schroeder, C., Fein, D., Mann, H., Lawlor, C., Marshall, J., Klein, A., Poutsiaka, D., Breeze, J. L., Joshi, R., Mathew, P.
10.1101/2021.05.29.21258010 — Posted: 2021-06-02
CorCast: A Distributed Architecture for Bayesian Epidemic Nowcasting and its Application to District-Level SARS-CoV-2 Infection Numbers in Germany
Hildebrandt, A.-K., Bob, K., Teschner, D., Kemmer, T., Leclaire, J., Schmidt, B., Hildebrandt, A.
10.1101/2021.06.02.21258209 — Posted: 2021-06-02
The Impact of COVID-19 Lockdowns on Mental Health Patient Populations: Evidence from Medical Claims Data
Ferwana, I., Varshney, L. R.
10.1101/2021.05.26.21257598 — Posted: 2021-06-02
IL10RB as a key regulator of COVID-19 host susceptibility and severity
Voloudakis, G., Hoffman, G., Venkatesh, S., Lee, K. M., Dobrindt, K., Vicari, J., Zhang, W., Beckmann, N. D., Jiang, S., Hoagland, D., Bian, J., Gao, L., Corvelo, A., Cho, K., Lee, J. S., Iyengar, S. K., Luoh, S.-W., Akbarian, S., Striker, R., Assimes, T. L., Schadt, E. E., Merad, M., tenOever, B. R., Charney, A. W., Brennand, K. J., Lynch, J. A., Fullard, J. F., Roussos, P.
10.1101/2021.05.31.21254851 — Posted: 2021-06-02
SARS-CoV-2 Infects Syncytiotrophoblast and Activates Inflammatory Responses in the Placenta
Argueta, L. B., Lacko, L. A., Bram, Y., Tada, T., Carrau, L., Zhang, T., Uhl, S., Lubor, B. C., Chandar, V., Gil, C., Zhang, W., Dodson, B., Bastiaans, J., Prabhu, M., Salvatore, C. M., Yang, Y. J., Baergen, R. N., tenOever, B. R., Landau, N. R., Chen, S., Schwartz, R. E., Stuhlmann, H.
10.1101/2021.06.01.446676 — Posted: 2021-06-02
SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator
Hysenaj, L., Little, S., Kulhanek, K. R., Gbenedio, O., Rodriguez, L., Shen, A., Lone, J.-C., Lupin-Jimenez, L. C., Bonser, L., Serwas, N. K., Bahl, K., Mick, E., Li, J. Z., Ding, V., Matsumoto, S., Maishan, M. l., Fragiadakis, G., Jablons, D. M., Langelier, C. R., Matthay, M., Ott, M., Sil, A., Krummel, M., Combes, A. J., Erle, D. M., Kratz, J. R., Roose, J. P.
10.1101/2021.06.01.446640 — Posted: 2021-06-02
Efficacy of ancestral receptor-binding domain, S1 and trimeric spike protein vaccines against SARS-CoV-2 variants B.1.1.7, B.1.351, and B.1.617.1
Yang, Y., Zang, J., Xu, S., Zhang, X., Yuan, S., Lavillette, D., Zhang, C., Huang, Z.
10.1101/2021.06.02.446698 — Posted: 2021-06-02
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking
Shiakolas, A. R., Johnson, N., Kramer, K. J., Suryadevara, N., Wrapp, D., Periasamy, S., Pilewski, K. A., Raju, N., Nargi, R., Sutton, R. E., Walker, L., Crowe, J. E., Bukreyev, A., Carnahan, R. H., McLellan, J. S., Georgiev, I. S.
10.1101/2021.06.02.446813 — Posted: 2021-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).